本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Castle Biosciences, Inc.

18.91
+0.37002.00%
成交量:33.55萬
成交額:629.48萬
市值:5.46億
市盈率:-102.51
高:19.06
開:18.51
低:17.89
收:18.54
資料載入中...
2019/07/23

SEC問詢函

[Cover]Correspondence
2019/07/19

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/07/19

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/07/15

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/26

招股説明書

General form for registration of securities under the Securities Act of 1933
2007/08/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2007/07/10

交易所摘牌聲明

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2007/05/14

季度報告

Quarterly report [Sections 13 or 15(d)]
2007/05/14

重要事件披露

Current report, items 2.02 and 9.01
2007/05/11

持股變動聲明

Statement of changes in beneficial ownership of securities
2007/04/30

企業合併公告

Prospectuses and communications, business combinations
2007/04/30

重要事件披露

Current report, items 1.01 and 9.01
2007/04/30

[修訂]年度報告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2007/04/19

持股變動聲明

Statement of changes in beneficial ownership of securities
2007/03/30

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2007/02/20

重要事件披露

Current report, items 2.02 and 9.01
2007/01/23

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2006/12/19

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2006/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2006/11/13

季度報告

Quarterly report [Sections 13 or 15(d)]